Gapping down
In reaction to earnings/guidance:
- OKTA -19.3%, AI -17.6%, VSCO -13.3%, NCNO -12.7%, CRWD -9.9% (also granted Impact Level 5 Provisional Authorization from DoD), M -9.5%, DG -9.1%, CRM -6.3%, PVH -2.7%, CAL -1.5%
Other news:
- LXRX -17% (stock offering)
- LCID -13.1% (offering of 173544948 shares of its common stock for aggregate gross proceeds to Lucid of approximately $1.2 bln)
- CRON -5.1% (to exit existing US hemp-derived CBD-focused ops)
- BDSX -3.6% (announces three abstracts to be presented at ASCO 2023 Annual Meeting)
- OCS -2% (pricing of a follow-on public offering of 3500000 ordinary shares at a public offering price of $11.50 per ordinary share)
- NIO -2% (May deliveries)
- XPEV -0.8% (May deliveries)
- LI -0.6% (May deliveries)
Analyst comments:
- ACET -4.6% (downgraded to Neutral from Overweight at JP Morgan)
- SPHR -1.1% (downgraded to Neutral from Outperform at Macquarie)